Postma Robert W. - 06 Jun 2024 Form 4 Insider Report for Alaunos Therapeutics, Inc. (TCRT)

Reporting relationship: Director
Issuer ticker: TCRT
Reported as of: 06 Jun 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Jun 2024, 17:00:08 UTC
Prior SEC filing: 08 Jun 2023
Next SEC filing: 15 Apr 2025
Source filing: View source filing
Reporting owner signature: /s/ Melinda Lackey, Attorney-in-Fact

Key filing fact

Postma Robert W. filed Form 4 for Alaunos Therapeutics, Inc. (TCRT) on 10 Jun 2024.

Key facts

This page summarizes Postma Robert W.'s Form 4 filing for Alaunos Therapeutics, Inc. (TCRT).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 10 Jun 2024, 17:00.

Change

Previous filing in this sequence was filed on 08 Jun 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TCRT transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value: $0
Shares: +12,800
Change %
Price: $0.000000
Shares after: 12,800
Date: 06 Jun 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 12,800
Exercise price: $1.03
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

One-twelfth of the Option vests each month on the monthly anniversary of June 6, 2024, with any amount that remains unvested on the date immediately preceding the Company's 2025 annual general meeting of stockholders vesting thereon.